From: Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea
Persistent symptoms or signs | Factors | Univariate OR | Multivariate OR | ||
---|---|---|---|---|---|
95% CI | P value | 95% CI | P value | ||
Fatigue |  ≥ Moderate severity | 2.33 (0.98–5.24) | 0.045 | 2.02 (0.82–4.72) | 0.114 |
 ≥ 50 years old | 2.17 (1.06–4.40) | 0.031 | 2.00 (0.94–4.18) | 0.066 | |
Female sex | 2.01 (0.91–4.91) | 0.099 | 2.22 (0.99–5.53) | 0.066 | |
Anxiety |  ≥ Moderate severity | 2.78 (1.20–6.19) | 0.014 | 2.89 (1.24–6.49) | 0.011 |
 ≥ 50 years old | 1.10 (0.51–2.28) | 0.796 | – | – | |
Female sex | 1.69 (0.79–3.97) | 0.198 | 1.78 (0.82–4.24) | 0.163 | |
Depression |  ≥ Moderate severity | 1.13 (0.43–2.67) | 0.786 | – | – |
 ≥ 50 years old | 1.22 (0.59–2.45) | 0.576 | – | – | |
Female sex | 2.34 (1.08–5.68) | 0.043 | 2.34 (1.08–5.68) | 0.043 | |
Insomnia |  ≥ Moderate severity | 1.74 (0.65–4.21) | 0.242 | – | – |
 ≥ 50 years old | 1.33 (0.59–2.88) | 0.477 | – | – | |
Female sex | 2.84 (1.13–8.65) | 0.040 | 2.84 (1.13–8.65) | 0.040 | |
Concentration difficulty |  ≥ Moderate severity | 2.76 (1.03–4.79) | 0.036 | 2.06 (0.91–4.52) | 0.076 |
 ≥ 50 years old | 1.79 (0.94–3.38) | 0.073 | 1.63 (0.83–3.17) | 0.150 | |
Female sex | 1.86 (0.94–3.93) | 0.085 | 2.01 (1.00–4.31) | 0.058 | |
Cognitive dysfunction |  ≥ Moderate severity | 1.81 (0.80–3.92) | 0.139 | 1.51 (0.64–3.41) | 0.328 |
 ≥ 50 years old | 2.24 (1.17–4.27) | 0.014 | 2.19 (1.11–4.29) | 0.022 | |
Female sex | 1.94 (0.96–4.19) | 0.077 | 2.11 (1.03–4.64) | 0.051 | |
Amnesia |  ≥ Moderate severity | 1.42 (0.59–3.16) | 0.409 | – | – |
 ≥ 50 years old | 2.04 (1.05–3.94) | 0.033 | 2.20 (1.12–4.32) | 0.021 | |
Female sex | 2.78 (1.29–6.71) | 0.014 | 2.97 (1.36–7.24) | 0.010 | |
Anosmia |  ≥ Moderate severity | 0.39 (0.02–2.04) | 0.370 | – | – |
 ≥ 50 years old | 2.26 (0.76–6.56) | 0.129 | 2.26 (0.76–6.56) | 0.129 | |
Female sex | 1.31 (0.43–4.86) | 0.651 | – | – | |
Ageusia |  ≥ Moderate severity | 0.81 (0.04–4.74) | 0.844 | – | – |
 ≥ 50 years old | 4.31 (1.03–21.49) | 0.050 | 4.31 (1.03–21.49) | 0.050 | |
Female sex | 0.46 (0.11–1.98) | 0.276 | – | – |